Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study
Megan McLeod,Julie Torode,Kari Leung,Nirmala Bhoo-Pathy,Christopher Booth,Jade Chakowa,Julie Gralow,Andre Ilbawi,Jacek Jassem,Jeannette Parkes,Merixtell Mallafré-Larrosa,Miriam Mutebi,CS Pramesh,Manju Sengar,Audrey Tsunoda,Karla Unger-Saldaña,Verna Vanderpuye,Aasim Yusuf,Richard Sullivan,Ajay Aggarwal
DOI: https://doi.org/10.1016/s1470-2045(23)00568-5
IF: 54.433
2024-02-01
The Lancet Oncology
Abstract:Summary This Policy Review sourced opinions from experts in cancer care across low-income and middle-income countries (LMICs) to build consensus around high-priority measures of care quality. A comprehensive list of quality indicators in medical, radiation, and surgical oncology was identified from systematic literature reviews . A modified Delphi study consisting of three 90-min workshops and two international electronic surveys integrating a global range of key clinical, policy, and research leaders was used to derive consensus on cancer quality indicators that would be both feasible to collect and were high priority for cancer care systems in LMICs. Workshop participants narrowed the list of 216 quality indicators from the literature review to 34 for inclusion in the subsequent surveys. Experts' responses to the surveys showed consensus around nine high-priority quality indicators for measuring the quality of hospital-based cancer care in LMICs. These quality indicators focus on important processes of care delivery from accurate diagnosis (eg, histologic diagnosis via biopsy and TNM staging) to adequate, timely, and appropriate treatment (eg, completion of radiotherapy and appropriate surgical intervention). The core indicators selected could be used to implement systems of feedback and quality improvement.
oncology